You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
With $10 billion in federal funding supporting school screening, labs, vendors, and various other institutions are ramping up efforts to roll out K-12 testing programs.
Iqvia and Quest established Q2 solutions, originally known as Quintiles Research, as a joint venture in 2015 with Quest owning 40 percent of the firm.
The company signed a non-exclusive license for Zora's ceramide markers and plans to launch a test based on the markers as early as next year.
News items for the in vitro diagnostics industry for the week of March 8, 2021.
Quest will pick up the business from 29 Mercy hospital labs and two independent clinic labs servicing patients and providers throughout the Midwest.
Labs like Biodesix, ARUP, Quest, and Labcorp engaged different strategies to prevent loss of patient samples during recent extreme weather.
News items for the in vitro diagnostics industry for the week of Feb. 22, 2021.
While serology has been little used throughout the pandemic, the vaccine rollout presents new opportunities both for research and clinical use.
The lab will use its phlebotomy network to help Grail with specimen collection for its Galleri multi-cancer early detection blood test, slated to launch this year.
News items for the in vitro diagnostics industry for the week of Feb. 15, 2021.